Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Beyond Quality: PAT as a Catalyst for Carbon Reduction in Pharma
Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)
Pall Corporation
View All Featured ArticlesHeadline News
FDA approves subcutaneous SKYRIZI induction regimen for Crohn’s disease
Mo-Rez shows 62% response rate in platinum-resistant ovarian cancer
Olomorasib shows durable first-line activity in KRAS G12C-mutant lung cancer
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Characterisation of Host-Cell Proteins using Mass Spectrometry Enables Effective Purification Optimisation
Presented by Dr Li Zang of Biogen
31st October 2017
In-line monitoring of surfactant clearance in viral vaccine downstream processing
Presented by Marina Kirkitadze, Head of Process Support & PAT Platform, Analytical Sciences at Sanofi Pasteur
15th February 2022
Novel Technologies That Aid the Detection and Differentiation of Proteinaceous Impurities in Biologic Drug Substances and Drug Product
Presented by Danny Chou, President and Founder at Compassion BioSolution, LLC
30th November 2020
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
Lifetime study for JSR Amsphere A3 – protein A resin
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
